Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Multiple sclerosis may lead to mild short-term memory loss that can affect your ability to recall information. Lifestyle changes could help you manage symptoms. Multiple sclerosis (MS) is a ...

Eating and swallowing issues, along with meal planning and prep, can become challenging due to MS symptoms such as fatigue and tremors.

A new study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease and ...

A progressive disease such as multiple sclerosis might be better managed ... is typically treated by gradual reinstitution of oral baclofen. In the case of serious withdrawal, intravenous ...

Hormonal changes at puberty may trigger disease activity, but DMTs reduced the risk, indicating more aggressive treatment may be warranted.

If you are interested in arranging phone or on-site interviews (including photo or video shoots) with UCSF faculty or staff, please contact the Public Affairs representative who covers the topic you ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

Biogen Inc. (NASDAQ:BIIB), currently valued at $19.15 billion by market capitalization, reported its earnings for the fourth ...